HTL SAS was created in 1992 as an independent company specialized in the manufacture, purification and research and development of Sodium Hyaluronate (HA).

It’s production is by biosynthesis using a natural, non OGM, bacterial strain (Mw from 1000 Dalton to 3 million Dalton). HTL’s production facility is certified GMP compliant, holds Certificates of Suitability with the European Pharmacopoeia several different qualities of HA, is ISO 9001: 2000 and has a Master File (MAF) filed with both the FDA (US) and the TGA (Australia). In addition, HTL’s raw material is formulated in many pharmaceutical and medical device products on the world market.